Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
41
ASG.V Quote, Financials, Valuation and Earnings
Last price:
$0.26
Seasonality move
:
12.32%
Day range:
$0.26 - $0.26
52-week range:
$0.24 - $0.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.79x
P/B ratio:
3.73x
Volume:
664
Avg. volume:
33.3K
1-year change:
-39.29%
Market cap:
$19.9M
Revenue:
$24.1M
EPS (TTM):
-$0.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ASG.V
Aurora Spine Corp.
|
-- | -- | -- | -- | -- |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ASG.V
Aurora Spine Corp.
|
$0.26 | -- | $19.9M | -- | $0.00 | 0% | 0.79x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
$0.05 | -- | $9.7M | -- | $0.00 | 0% | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0200 | -- | $205.5K | 0.52x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ASG.V
Aurora Spine Corp.
|
38.26% | -0.352 | 14.1% | 0.87x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
40.99% | -3.518 | 19.05% | 2.85x |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ASG.V
Aurora Spine Corp.
|
$1.6M | -$102.2K | -19.92% | -31.66% | -1.68% | $193.7K |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -$1.1M | -1117.27% | -- | -- | -$408.2K |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
Aurora Spine Corp. vs. Competitors
-
Which has Higher Returns ASG.V or COOL.CX?
Core One Labs, Inc. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of --. Aurora Spine Corp.'s return on equity of -31.66% beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ASG.VAurora Spine Corp.25.47% -$0.00 $8.6M COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About ASG.V or COOL.CX?
Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Spine Corp. has higher upside potential than Core One Labs, Inc., analysts believe Aurora Spine Corp. is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ASG.VAurora Spine Corp.0 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is ASG.V or COOL.CX More Risky?
Aurora Spine Corp. has a beta of -0.048, which suggesting that the stock is 104.813% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock ASG.V or COOL.CX?
Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ASG.V or COOL.CX?
Aurora Spine Corp. quarterly revenues are $6.1M, which are larger than Core One Labs, Inc. quarterly revenues of --. Aurora Spine Corp.'s net income of -$195.6K is higher than Core One Labs, Inc.'s net income of --. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.79x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ASG.VAurora Spine Corp.0.79x -- $6.1M -$195.6K COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns ASG.V or CURE.X.CX?
Biocure Technology has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of --. Aurora Spine Corp.'s return on equity of -31.66% beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ASG.VAurora Spine Corp.25.47% -$0.00 $8.6M CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About ASG.V or CURE.X.CX?
Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Spine Corp. has higher upside potential than Biocure Technology, analysts believe Aurora Spine Corp. is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings ASG.VAurora Spine Corp.0 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is ASG.V or CURE.X.CX More Risky?
Aurora Spine Corp. has a beta of -0.048, which suggesting that the stock is 104.813% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ASG.V or CURE.X.CX?
Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ASG.V or CURE.X.CX?
Aurora Spine Corp. quarterly revenues are $6.1M, which are larger than Biocure Technology quarterly revenues of --. Aurora Spine Corp.'s net income of -$195.6K is higher than Biocure Technology's net income of --. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.79x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ASG.VAurora Spine Corp.0.79x -- $6.1M -$195.6K CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns ASG.V or HEAL.CX?
has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of --. Aurora Spine Corp.'s return on equity of -31.66% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ASG.VAurora Spine Corp.25.47% -$0.00 $8.6M HEAL.CX-- -- -- -
What do Analysts Say About ASG.V or HEAL.CX?
Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Spine Corp. has higher upside potential than , analysts believe Aurora Spine Corp. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings ASG.VAurora Spine Corp.0 0 0 HEAL.CX0 0 0 -
Is ASG.V or HEAL.CX More Risky?
Aurora Spine Corp. has a beta of -0.048, which suggesting that the stock is 104.813% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ASG.V or HEAL.CX?
Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ASG.V or HEAL.CX?
Aurora Spine Corp. quarterly revenues are $6.1M, which are larger than quarterly revenues of --. Aurora Spine Corp.'s net income of -$195.6K is higher than 's net income of --. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.79x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ASG.VAurora Spine Corp.0.79x -- $6.1M -$195.6K HEAL.CX-- -- -- --
-
Which has Higher Returns ASG.V or LOBE.CX?
Lobe Sciences Ltd. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of --. Aurora Spine Corp.'s return on equity of -31.66% beat Lobe Sciences Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ASG.VAurora Spine Corp.25.47% -$0.00 $8.6M LOBE.CXLobe Sciences Ltd.-- -$0.01 $5.9M -
What do Analysts Say About ASG.V or LOBE.CX?
Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Lobe Sciences Ltd. has an analysts' consensus of -- which suggests that it could grow by 14192.33%. Given that Lobe Sciences Ltd. has higher upside potential than Aurora Spine Corp., analysts believe Lobe Sciences Ltd. is more attractive than Aurora Spine Corp..
Company Buy Ratings Hold Ratings Sell Ratings ASG.VAurora Spine Corp.0 0 0 LOBE.CXLobe Sciences Ltd.0 0 0 -
Is ASG.V or LOBE.CX More Risky?
Aurora Spine Corp. has a beta of -0.048, which suggesting that the stock is 104.813% less volatile than S&P 500. In comparison Lobe Sciences Ltd. has a beta of 0.215, suggesting its less volatile than the S&P 500 by 78.507%.
-
Which is a Better Dividend Stock ASG.V or LOBE.CX?
Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lobe Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Lobe Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ASG.V or LOBE.CX?
Aurora Spine Corp. quarterly revenues are $6.1M, which are larger than Lobe Sciences Ltd. quarterly revenues of --. Aurora Spine Corp.'s net income of -$195.6K is higher than Lobe Sciences Ltd.'s net income of -$1.1M. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Lobe Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.79x versus -- for Lobe Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ASG.VAurora Spine Corp.0.79x -- $6.1M -$195.6K LOBE.CXLobe Sciences Ltd.-- -- -- -$1.1M
-
Which has Higher Returns ASG.V or NSHS.CX?
NanoSphere Health Sciences, Inc. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of --. Aurora Spine Corp.'s return on equity of -31.66% beat NanoSphere Health Sciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ASG.VAurora Spine Corp.25.47% -$0.00 $8.6M NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M -
What do Analysts Say About ASG.V or NSHS.CX?
Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoSphere Health Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Spine Corp. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe Aurora Spine Corp. is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ASG.VAurora Spine Corp.0 0 0 NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 -
Is ASG.V or NSHS.CX More Risky?
Aurora Spine Corp. has a beta of -0.048, which suggesting that the stock is 104.813% less volatile than S&P 500. In comparison NanoSphere Health Sciences, Inc. has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.292%.
-
Which is a Better Dividend Stock ASG.V or NSHS.CX?
Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoSphere Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. NanoSphere Health Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ASG.V or NSHS.CX?
Aurora Spine Corp. quarterly revenues are $6.1M, which are larger than NanoSphere Health Sciences, Inc. quarterly revenues of --. Aurora Spine Corp.'s net income of -$195.6K is lower than NanoSphere Health Sciences, Inc.'s net income of -$13.1K. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while NanoSphere Health Sciences, Inc.'s PE ratio is 0.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.79x versus -- for NanoSphere Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ASG.VAurora Spine Corp.0.79x -- $6.1M -$195.6K NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 3.73% over the past day.
Buy
60
AAOI alert for Dec 26
Applied Optoelectronics, Inc. [AAOI] is down 9.39% over the past day.
